Device Trial Radar · NCT03385109
The TransEnterix European Patient Registry
Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
4,080
Actual
Start
Jul 25, 2017
Primary completion
Jun 17, 2026
Study completion Jun 17, 2026
Sponsor
- Lead sponsor
- Asensus SurgicalNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- RQM+
- First posted
- Dec 28, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open label observational registry trial in which participating centers enroll subjects who had or will have a laparoscopically assisted surgery using the Senhance Surgical System.
Conditions
- Surgery
Interventions
SurgeryDevice
Patients are approached surgically with the Senhance Surgical System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventTime frame: Surgery to 30 days post op
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St. Marien-Krankenhaus
Siegen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.